Visual Dysfunction in Diabetes: The Science of Patient Impairment and Health Care
An exciting contribution to the field, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement is designed with two overriding objectives: to help readers understand the impact of vision impairment in people living daily with diabetes rather than considering diabetic retino...
Gespeichert in:
Weitere Verfasser: | , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Totowa, NJ
Humana Press
2012
|
Ausgabe: | 1st ed. 2012 |
Schriftenreihe: | Ophthalmology Research
|
Schlagworte: | |
Online-Zugang: | UBR01 URL des Erstveröffentlichers |
Zusammenfassung: | An exciting contribution to the field, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement is designed with two overriding objectives: to help readers understand the impact of vision impairment in people living daily with diabetes rather than considering diabetic retinopathy solely as a medical problem, and to explore what we know and don't know about the ways diabetes affect the eye. With the plethora of new information being generated, there are still a series of fundamental questions that must be addressed if effective treatments for diabetic retinopathy are to be found and applied. Developed by a renowned group of authorities, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement offers responses and context for a range of questions, such as: do metabolic factors beyond glucose contribute to vision-threatening diabetic retinopathy? If so, how do these lead to vision impairment? Is diabetic retinopathy a response to systemic metabolic abnormalities or are there unique ocular problems related to insulin resistance? What is the relationship between the neural, vascular, and inflammatory abnormalities in diabetic retinopathy? Do they represent a pathological cascade induced sequentially or simultaneous responses to one or more metabolic perturbations? The authors note that if we do not address these types of questions, it is possible that the long process of developing new therapeutic s will target only one arm of the pathology and leave the retina open to damaging consequences of the others. State-of-the-art, comprehensive, and an invaluable addition the research and clinical literature, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement offers guidance and a significant step toward new scientific approaches that can lessen the devastating vision impairment associated with diabetes |
Beschreibung: | 1 Online-Ressource (XV, 379 Seiten 72 illus., 51 illus. in color.) |
ISBN: | 9781607611509 |
DOI: | 10.1007/978-1-60761-150-9 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV047942914 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 220414s2012 |||| o||u| ||||||eng d | ||
020 | |a 9781607611509 |9 978-1-60761-150-9 | ||
024 | 7 | |a 10.1007/978-1-60761-150-9 |2 doi | |
035 | |a (ZDB-2-SME)978-1-60761-150-9 | ||
035 | |a (OCoLC)1312689177 | ||
035 | |a (DE-599)BVBBV047942914 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 617.7 |2 23 | |
084 | |a YC 7075 |0 (DE-625)153252:12982 |2 rvk | ||
245 | 1 | 0 | |a Visual Dysfunction in Diabetes |b The Science of Patient Impairment and Health Care |c edited by Joyce Tombran-Tink, Colin J. Barnstable, Thomas W. Gardner |
250 | |a 1st ed. 2012 | ||
264 | 1 | |a Totowa, NJ |b Humana Press |c 2012 | |
300 | |a 1 Online-Ressource (XV, 379 Seiten 72 illus., 51 illus. in color.) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Ophthalmology Research | |
520 | |a An exciting contribution to the field, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement is designed with two overriding objectives: to help readers understand the impact of vision impairment in people living daily with diabetes rather than considering diabetic retinopathy solely as a medical problem, and to explore what we know and don't know about the ways diabetes affect the eye. With the plethora of new information being generated, there are still a series of fundamental questions that must be addressed if effective treatments for diabetic retinopathy are to be found and applied. Developed by a renowned group of authorities, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement offers responses and context for a range of questions, such as: do metabolic factors beyond glucose contribute to vision-threatening diabetic retinopathy? If so, how do these lead to vision impairment? Is diabetic retinopathy a response to systemic metabolic abnormalities or are there unique ocular problems related to insulin resistance? What is the relationship between the neural, vascular, and inflammatory abnormalities in diabetic retinopathy? Do they represent a pathological cascade induced sequentially or simultaneous responses to one or more metabolic perturbations? The authors note that if we do not address these types of questions, it is possible that the long process of developing new therapeutic s will target only one arm of the pathology and leave the retina open to damaging consequences of the others. State-of-the-art, comprehensive, and an invaluable addition the research and clinical literature, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement offers guidance and a significant step toward new scientific approaches that can lessen the devastating vision impairment associated with diabetes | ||
650 | 4 | |a Ophthalmology | |
650 | 4 | |a Endocrinology | |
650 | 4 | |a Neurosciences | |
650 | 4 | |a Ophthalmology | |
650 | 4 | |a Endocrinology | |
650 | 4 | |a Neurosciences | |
650 | 0 | 7 | |a Retinopathia diabetica |0 (DE-588)4177904-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Diabetes mellitus |0 (DE-588)4070446-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Augenkrankheit |0 (DE-588)4112627-0 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Diabetes mellitus |0 (DE-588)4070446-4 |D s |
689 | 0 | 1 | |a Augenkrankheit |0 (DE-588)4112627-0 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Retinopathia diabetica |0 (DE-588)4177904-6 |D s |
689 | 1 | |5 DE-604 | |
700 | 1 | |a Tombran-Tink, Joyce |4 edt | |
700 | 1 | |a Barnstable, Colin J. |4 edt | |
700 | 1 | |a Gardner, Thomas W. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781607611592 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781607611493 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781493961689 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-60761-150-9 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_2012 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-033324369 | ||
966 | e | |u https://doi.org/10.1007/978-1-60761-150-9 |l UBR01 |p ZDB-2-SME |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804183589829476352 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author2 | Tombran-Tink, Joyce Barnstable, Colin J. Gardner, Thomas W. |
author2_role | edt edt edt |
author2_variant | j t t jtt c j b cj cjb t w g tw twg |
author_facet | Tombran-Tink, Joyce Barnstable, Colin J. Gardner, Thomas W. |
building | Verbundindex |
bvnumber | BV047942914 |
classification_rvk | YC 7075 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-1-60761-150-9 (OCoLC)1312689177 (DE-599)BVBBV047942914 |
dewey-full | 617.7 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 617 - Surgery & related medical specialties |
dewey-raw | 617.7 |
dewey-search | 617.7 |
dewey-sort | 3617.7 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
discipline_str_mv | Medizin |
doi_str_mv | 10.1007/978-1-60761-150-9 |
edition | 1st ed. 2012 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04227nmm a2200625zc 4500</leader><controlfield tag="001">BV047942914</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">220414s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781607611509</subfield><subfield code="9">978-1-60761-150-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-60761-150-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-60761-150-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1312689177</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047942914</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">617.7</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 7075</subfield><subfield code="0">(DE-625)153252:12982</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Visual Dysfunction in Diabetes</subfield><subfield code="b">The Science of Patient Impairment and Health Care</subfield><subfield code="c">edited by Joyce Tombran-Tink, Colin J. Barnstable, Thomas W. Gardner</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2012</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XV, 379 Seiten 72 illus., 51 illus. in color.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Ophthalmology Research</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">An exciting contribution to the field, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement is designed with two overriding objectives: to help readers understand the impact of vision impairment in people living daily with diabetes rather than considering diabetic retinopathy solely as a medical problem, and to explore what we know and don't know about the ways diabetes affect the eye. With the plethora of new information being generated, there are still a series of fundamental questions that must be addressed if effective treatments for diabetic retinopathy are to be found and applied. Developed by a renowned group of authorities, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement offers responses and context for a range of questions, such as: do metabolic factors beyond glucose contribute to vision-threatening diabetic retinopathy? If so, how do these lead to vision impairment? Is diabetic retinopathy a response to systemic metabolic abnormalities or are there unique ocular problems related to insulin resistance? What is the relationship between the neural, vascular, and inflammatory abnormalities in diabetic retinopathy? Do they represent a pathological cascade induced sequentially or simultaneous responses to one or more metabolic perturbations? The authors note that if we do not address these types of questions, it is possible that the long process of developing new therapeutic s will target only one arm of the pathology and leave the retina open to damaging consequences of the others. State-of-the-art, comprehensive, and an invaluable addition the research and clinical literature, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement offers guidance and a significant step toward new scientific approaches that can lessen the devastating vision impairment associated with diabetes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrinology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurosciences</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrinology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurosciences</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Retinopathia diabetica</subfield><subfield code="0">(DE-588)4177904-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Diabetes mellitus</subfield><subfield code="0">(DE-588)4070446-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Augenkrankheit</subfield><subfield code="0">(DE-588)4112627-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Diabetes mellitus</subfield><subfield code="0">(DE-588)4070446-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Augenkrankheit</subfield><subfield code="0">(DE-588)4112627-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Retinopathia diabetica</subfield><subfield code="0">(DE-588)4177904-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tombran-Tink, Joyce</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barnstable, Colin J.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gardner, Thomas W.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781607611592</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781607611493</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781493961689</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-60761-150-9</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_2012</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033324369</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-60761-150-9</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV047942914 |
illustrated | Not Illustrated |
index_date | 2024-07-03T19:35:40Z |
indexdate | 2024-07-10T09:25:51Z |
institution | BVB |
isbn | 9781607611509 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033324369 |
oclc_num | 1312689177 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XV, 379 Seiten 72 illus., 51 illus. in color.) |
psigel | ZDB-2-SME ZDB-2-SME_2012 |
publishDate | 2012 |
publishDateSearch | 2012 |
publishDateSort | 2012 |
publisher | Humana Press |
record_format | marc |
series2 | Ophthalmology Research |
spelling | Visual Dysfunction in Diabetes The Science of Patient Impairment and Health Care edited by Joyce Tombran-Tink, Colin J. Barnstable, Thomas W. Gardner 1st ed. 2012 Totowa, NJ Humana Press 2012 1 Online-Ressource (XV, 379 Seiten 72 illus., 51 illus. in color.) txt rdacontent c rdamedia cr rdacarrier Ophthalmology Research An exciting contribution to the field, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement is designed with two overriding objectives: to help readers understand the impact of vision impairment in people living daily with diabetes rather than considering diabetic retinopathy solely as a medical problem, and to explore what we know and don't know about the ways diabetes affect the eye. With the plethora of new information being generated, there are still a series of fundamental questions that must be addressed if effective treatments for diabetic retinopathy are to be found and applied. Developed by a renowned group of authorities, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement offers responses and context for a range of questions, such as: do metabolic factors beyond glucose contribute to vision-threatening diabetic retinopathy? If so, how do these lead to vision impairment? Is diabetic retinopathy a response to systemic metabolic abnormalities or are there unique ocular problems related to insulin resistance? What is the relationship between the neural, vascular, and inflammatory abnormalities in diabetic retinopathy? Do they represent a pathological cascade induced sequentially or simultaneous responses to one or more metabolic perturbations? The authors note that if we do not address these types of questions, it is possible that the long process of developing new therapeutic s will target only one arm of the pathology and leave the retina open to damaging consequences of the others. State-of-the-art, comprehensive, and an invaluable addition the research and clinical literature, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement offers guidance and a significant step toward new scientific approaches that can lessen the devastating vision impairment associated with diabetes Ophthalmology Endocrinology Neurosciences Endocrinology Retinopathia diabetica (DE-588)4177904-6 gnd rswk-swf Diabetes mellitus (DE-588)4070446-4 gnd rswk-swf Augenkrankheit (DE-588)4112627-0 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Diabetes mellitus (DE-588)4070446-4 s Augenkrankheit (DE-588)4112627-0 s DE-604 Retinopathia diabetica (DE-588)4177904-6 s Tombran-Tink, Joyce edt Barnstable, Colin J. edt Gardner, Thomas W. edt Erscheint auch als Druck-Ausgabe 9781607611592 Erscheint auch als Druck-Ausgabe 9781607611493 Erscheint auch als Druck-Ausgabe 9781493961689 https://doi.org/10.1007/978-1-60761-150-9 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Visual Dysfunction in Diabetes The Science of Patient Impairment and Health Care Ophthalmology Endocrinology Neurosciences Endocrinology Retinopathia diabetica (DE-588)4177904-6 gnd Diabetes mellitus (DE-588)4070446-4 gnd Augenkrankheit (DE-588)4112627-0 gnd |
subject_GND | (DE-588)4177904-6 (DE-588)4070446-4 (DE-588)4112627-0 (DE-588)4143413-4 |
title | Visual Dysfunction in Diabetes The Science of Patient Impairment and Health Care |
title_auth | Visual Dysfunction in Diabetes The Science of Patient Impairment and Health Care |
title_exact_search | Visual Dysfunction in Diabetes The Science of Patient Impairment and Health Care |
title_exact_search_txtP | Visual Dysfunction in Diabetes The Science of Patient Impairment and Health Care |
title_full | Visual Dysfunction in Diabetes The Science of Patient Impairment and Health Care edited by Joyce Tombran-Tink, Colin J. Barnstable, Thomas W. Gardner |
title_fullStr | Visual Dysfunction in Diabetes The Science of Patient Impairment and Health Care edited by Joyce Tombran-Tink, Colin J. Barnstable, Thomas W. Gardner |
title_full_unstemmed | Visual Dysfunction in Diabetes The Science of Patient Impairment and Health Care edited by Joyce Tombran-Tink, Colin J. Barnstable, Thomas W. Gardner |
title_short | Visual Dysfunction in Diabetes |
title_sort | visual dysfunction in diabetes the science of patient impairment and health care |
title_sub | The Science of Patient Impairment and Health Care |
topic | Ophthalmology Endocrinology Neurosciences Endocrinology Retinopathia diabetica (DE-588)4177904-6 gnd Diabetes mellitus (DE-588)4070446-4 gnd Augenkrankheit (DE-588)4112627-0 gnd |
topic_facet | Ophthalmology Endocrinology Neurosciences Endocrinology Retinopathia diabetica Diabetes mellitus Augenkrankheit Aufsatzsammlung |
url | https://doi.org/10.1007/978-1-60761-150-9 |
work_keys_str_mv | AT tombrantinkjoyce visualdysfunctionindiabetesthescienceofpatientimpairmentandhealthcare AT barnstablecolinj visualdysfunctionindiabetesthescienceofpatientimpairmentandhealthcare AT gardnerthomasw visualdysfunctionindiabetesthescienceofpatientimpairmentandhealthcare |